KalVista Pharmaceuticals, Inc. (KALV)
26.71
-0.01
(-0.04%)
USD |
NASDAQ |
May 07, 16:00
26.75
+0.04
(+0.15%)
After-Hours: 07:08
KalVista Pharmaceuticals Total Liabilities (Quarterly) : 338.09M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 170.73M |
| Recursion Pharmaceuticals, Inc. | 314.75M |
| Tango Therapeutics, Inc. | 63.83M |
| BioCryst Pharmaceuticals, Inc. | -- |
| Iovance Biotherapeutics, Inc. | 214.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 335.38M |
| Shareholders Equity (Quarterly) | -2.711M |
| Debt to Equity Ratio | -104.83 |
| Current Ratio | 5.582 |
| Net Debt Paydown Yield | -6.76% |